New imaging biomarker for predicting tumor aggressiveness. Scottsdale, Arizona – Imaging Endpoints announced today that the U.S. Patent and Trademark Office has issued Patent No. 10,854,338 – “PREDICTING BREAST CANCER RESPONSIVENESS TO HORMONE TREATMENT USING QUANTITATIVE TEXTURAL ANALYSIS” to Imaging… Read More
Imaging Endpoints is a dynamic organization that’s widely considered the leading imaging CRO (iCRO) within oncology and complex clinical trials. We work passionately toward our mission to Connect Imaging to the CureTM for the benefit of all humanity. Since its… Read More
AI is making a significant impact for breast cancer detection in mammography and breast tomosynthesis. Read this recent overview of the concepts and developments in the field at https://www.sciencedirect.com/science/article/pii/S1044579X20301358. To learn more about how Imaging Endpoints utilizes AI and other… Read More
Today is World Pancreatic Cancer Day, where people around the world unite in the fight against one of the world’s deadliest cancers. Imaging Endpoints is the leading imaging CRO in the battle against pancreatic cancer, and our team is passionately… Read More
REAL-TIME READS: Imaging Endpoints leverages its global infrastructure to provide real-time read results to sponsors and their clinical sites in over 35 countries. Each month the Company performs thousands of real-time reads; typically providing eligibility reads within one day and… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
